Literature DB >> 2850966

cAMP acts in synergy with E1A protein to activate transcription of the adenovirus early genes E4 and E1A.

D A Engel1, S Hardy, T Shenk.   

Abstract

The transcriptional control regions of several E1A-inducible adenovirus early genes contain sequences similar to the cAMP response element of several cellular cAMP-inducible genes. The cAMP-responsive cell line S49 was infected with wild-type adenovirus and found to contain elevated levels of mRNAs encoded by all early genes tested (E4, E1A, and E1B), following treatment with dibutyryl cAMP. This effect was at the level of transcriptional activation. The effect of cAMP on E4 and E1A transcription was greater in cells infected with wild-type virus than in cells infected with virus that lacked functional E1A proteins. cAMP in combination with E1A generated a greater induction than the product of the increases achieved by each inducer alone. Therefore, cAMP acted in synergy with E1A to induce maximally transcription of the E4 and E1A genes. These data suggest that E1A or E1A-stimulated events can interact functionally with targets of cAMP signaling in the cell to induce transcription of the adenovirus early genes.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2850966     DOI: 10.1101/gad.2.12a.1517

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  38 in total

1.  Induction of p53-independent apoptosis by the adenovirus E4orf4 protein requires binding to the Balpha subunit of protein phosphatase 2A.

Authors:  R C Marcellus; H Chan; D Paquette; S Thirlwell; D Boivin; P E Branton
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  Induction of AP-1 DNA-binding activity and c-fos mRNA by the adenovirus 243R E1A protein and cyclic AMP requires domains necessary for transformation.

Authors:  R W Gedrich; S T Bayley; D A Engel
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

3.  Adenovirus E4orf4 protein reduces phosphorylation of c-Fos and E1A proteins while simultaneously reducing the level of AP-1.

Authors:  U Müller; T Kleinberger; T Shenk
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

Review 4.  Expression and interactions of human adenovirus oncoproteins.

Authors:  P A Boulanger; G E Blair
Journal:  Biochem J       Date:  1991-04-15       Impact factor: 3.857

5.  Induction of c-fos mRNA and AP-1 DNA-binding activity by cAMP in cooperation with either the adenovirus 243- or the adenovirus 289-amino acid E1A protein.

Authors:  D A Engel; U Muller; R W Gedrich; J S Eubanks; T Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

6.  Protein kinase A-dependent binding of a nuclear factor to the 21-base-pair repeat of the human T-cell leukemia virus type I long terminal repeat.

Authors:  H T Poteat; F Y Chen; P Kadison; J G Sodroski; W A Haseltine
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

7.  The adenovirus EII early promoter has multiple EIA-sensitive elements, two of which function cooperatively in basal and virus-induced transcription.

Authors:  C F Manohar; J Kratochvil; B Thimmapaya
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

8.  The adenovirus E4 17-kilodalton protein complexes with the cellular transcription factor E2F, altering its DNA-binding properties and stimulating E1A-independent accumulation of E2 mRNA.

Authors:  M J Marton; S B Baim; D A Ornelles; T Shenk
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

9.  Distinguishable promoter elements are involved in transcriptional activation by E1a and cyclic AMP.

Authors:  K A Lee; J S Fink; R H Goodman; M R Green
Journal:  Mol Cell Biol       Date:  1989-10       Impact factor: 4.272

10.  Adenovirus E1A specifically blocks SWI/SNF-dependent transcriptional activation.

Authors:  M E Miller; B R Cairns; R S Levinson; K R Yamamoto; D A Engel; M M Smith
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.